Cite
Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysis
MLA
Daniele Ughi, et al. “Characterization of the Phase I and Phase II Metabolic Profile of Tolvaptan by in Vitro Studies and Liquid Chromatography-Mass Spectrometry Profiling: Relevance to Doping Control Analysis.” Journal of Pharmaceutical and Biomedical Analysis, vol. 145, Apr. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c1757177ec8cfcbfb1d9acb642e64020&authtype=sso&custid=ns315887.
APA
Daniele Ughi, Xavier de la Torre, Valeria Buccilli, Monica Mazzarino, Francesco Botrè, Amelia Palermo, & Ilaria Fiacco. (2017). Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysis. Journal of Pharmaceutical and Biomedical Analysis, 145.
Chicago
Daniele Ughi, Xavier de la Torre, Valeria Buccilli, Monica Mazzarino, Francesco Botrè, Amelia Palermo, and Ilaria Fiacco. 2017. “Characterization of the Phase I and Phase II Metabolic Profile of Tolvaptan by in Vitro Studies and Liquid Chromatography-Mass Spectrometry Profiling: Relevance to Doping Control Analysis.” Journal of Pharmaceutical and Biomedical Analysis 145 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c1757177ec8cfcbfb1d9acb642e64020&authtype=sso&custid=ns315887.